Gravitas 309 - JAK1 Inhibitor in cGVHD first line (#1137)
Laufzeit: 01.01.2020 - 31.12.2023
imported
Kurzfassung
A phase 2/3 study of Itacitinib or placebo in combination with corticosteroids as initial treatment for chronic Graft-Versus-Host Disease
